What can we learn about influenza infection and vaccination from transcriptomics?

References

• Tamura S, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis. 2004;57:236–47.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Tsukamoto H, Kouwaki T, Seya T, Oshiumi H. Recognition of Viral RNA by Pattern Recognition Receptors in the Induction of Innate Immunity and Excessive Inflammation During Respiratory Viral Infections. Viral Immunol. 2017;30(6):408–20. doi:10.1089/vim.2016.0178.
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413(6857):732–38. doi:10.1038/35099560.
   PubMed Web of Science ®Google Scholar
• Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, et al. Innate immunity and the inter-exposure interval determine the dynamics of secondary influenza virus infection and explain observed viral hierarchies. PLoS Comput Biol. 2015;11(8):e1004334. doi:10.1371/journal.pcbi.1004334.
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S. Role of NK cells in influenza infection. Curr Top Microbiol Immunol. 2015;386:109–20. doi:10.1007/82_2014_403.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14(5):315–28. doi:10.1038/nri3665.
   PubMed Web of Science ®Google Scholar
• Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, Caniza MA, Hertz T, Devincenzo JP, Webby RJ, et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med. 2014;189(4):449–62. doi:10.1164/rccm.201309-1616OC.
   PubMed Web of Science ®Google Scholar
• Brown DM, Lampe AT, Workman AM. The differentiation and protective function of cytolytic CD4 T cells in influenza infection. Front Immunol. 2016;7:93. doi:10.3389/fimmu.2016.00093.
   PubMed Web of Science ®Google Scholar
• Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol. 2012;12:295. doi:10.1038/nri3166.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science (New York, NY). 2012;335(6071):936–41. doi:10.1126/science.1214935.
   Google Scholar
• Pizzolla A, Nguyen THO, Sant S, Jaffar J, Loudovaris T, Mannering SI, Thomas PG, Westall GP, Kedzierska K, Wakim LM. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128(2):721–33. doi:10.1172/JCI96957.
   PubMed Web of Science ®Google Scholar
• Zhao H, Liao X, Kang Y. Tregs: where we are and what comes next? Front Immunol. 2017;8:1578. doi:10.3389/fimmu.2017.01578.
   PubMed Web of Science ®Google Scholar
• Avnir Y, Tallarico AS, Zhu Q, Bennett AS, Connelly G, Sheehan J, Sui J, Fahmy A, Huang C-Y, Cadwell G, et al. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS Pathog. 2014;10(5):e1004103. doi:10.1371/journal.ppat.1004103.
   PubMed Web of Science ®Google Scholar
• Fonville JM, Fraaij PL, de Mutsert G, Wilks SH, van Beek R, Fouchier RAM, Rimmelzwaan GF. Antigenic maps of influenza A(H3N2) produced with human antisera obtained after primary infection. J Infect Dis. 2016;213(1):31–38. doi:10.1093/infdis/jiv367.
   PubMed Web of Science ®Google Scholar
• Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Antibody to influenza virus neuraminidase: an independent correlate of protection. J Infect Dis. 2015;212(8):1191–99. doi:10.1093/infdis/jiv195.
   PubMed Web of Science ®Google Scholar
• Halbherr SJ, Ludersdorfer TH, Ricklin M, Locher S, Berger Rentsch M, Summerfield A, Zimmer G. Biological and protective properties of immune sera directed to the influenza virus neuraminidase. J Virol. 2015;89(3):1550–63. doi:10.1128/JVI.02949-14.
   PubMed Web of Science ®Google Scholar
• Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M, Kent SJ, et al. Influenza-specific antibody-dependent phagocytosis. PLoS One. 2016;11(4):e0154461. doi:10.1371/journal.pone.0154461.
   PubMed Web of Science ®Google Scholar
• Jegaskanda S, Luke C, Hickman HD, Sangster MY, Wieland-Alter WF, McBride JM, Yewdell JW, Wright PF, Treanor J, Rosenberger CM, et al. Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge. J Infect Dis. 2016;214(6):945–52. doi:10.1093/infdis/jiw262.
   PubMed Web of Science ®Google Scholar
• He W, Tan GS, Mullarkey CE, Lee AJ, Lam MMW, Krammer F, Henry C, Wilson PC, Ashkar AA, Palese P, et al. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proc Natl Acad Sci U S A. 2016;113(42):11931–36. doi:10.1073/pnas.1609316113.
   PubMed Web of Science ®Google Scholar
• Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, et al. Characterization of pandemic influenza immune memory signature after vaccination or infection. J Clin Invest. 2014;124(7):3129–36. doi:10.1172/JCI74565.
   PubMed Web of Science ®Google Scholar
• Mejias A, Dimo B, Suarez NM, Garcia C, Suarez-Arrabal MC, Jartti T, Blankenship D, Jordan-Villegas A, Ardura MI, Xu Z, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 2013;10(11):e1001549. doi:10.1371/journal.pmed.1001549.
   PubMed Web of Science ®Google Scholar
• Parnell GP, McLean AS, Booth DR, Armstrong NJ, Nalos M, Huang SJ, Manak J, Tang W, Tam O-Y, Chan S, et al. A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia. Crit Care. 2012;16(4):R157. doi:10.1186/cc11477.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Franco LM, Atmar RL, Quarles JM, Arden N, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, et al. Host transcriptional response to influenza and other acute respiratory viral infections–A prospective cohort study. PLoS Pathog. 2015;11(6):e1004869. doi:10.1371/journal.ppat.1004869.
   PubMed Web of Science ®Google Scholar
• Andres-Terre M, McGuire HM, Pouliot Y, Bongen E, Sweeney TE, Tato CM, Khatri P. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses. Immunity. 2015;43(6):1199–211. doi:10.1016/j.immuni.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Yongsheng Huang, Aimee K. Zaas, Arvind Rao, Nicolas Dobigeon, Peter J. Woolf, Timothy Veldman, N. Christine Øien, Micah T. McClain, Jay B. Varkey, Bradley Nicholson, et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet. 2011;7(8):e1002234. doi:10.1371/journal.pgen.1002138.
   Google Scholar
• Hoang LT, Tolfvenstam T, Ooi EE, Khor CC, Naim ANM, Ho EXP, Ong SH, Wertheim HF, Fox A, Van Vinh Nguyen C, et al. Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity. PLoS One. 2014;9(11):e111640. doi:10.1371/journal.pone.0111640.
   PubMed Web of Science ®Google Scholar
• Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. MBio. 2014;5(1):e01102–01113. doi:10.1128/mBio.01102-13.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li G-M, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011;12(8):786–95. doi:10.1038/ni.2067.
   PubMed Web of Science ®Google Scholar
• Cao RG, Suarez NM, Obermoser G, Lopez SMC, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, et al. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J Infect Dis. 2014;210(2):224–33. doi:10.1093/infdis/jiu079.
   PubMed Web of Science ®Google Scholar
• Cole KS, Martin JM, Horne WT, Lin CJ, Nowalk MP, Alcorn JF, Zimmerman RK. Differential gene expression elicited by children in response to the 2015–16 live attenuated versus inactivated influenza vaccine. Vaccine. 2017;35(49 Pt B):6893–97. doi:10.1016/j.vaccine.2017.09.019.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A. 2016;113(7):1853–58. doi:10.1073/pnas.1519690113.
   PubMed Web of Science ®Google Scholar
• Kurupati R, Kossenkov A, Haut L, Kannan S, Xiang Z, Li Y, Doyle S, Liu Q, Schmader K, Showe L, et al. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. 2016;7(39):62898–911. doi:10.18632/oncotarget.11704.
   PubMedGoogle Scholar
• Tan Y, Tamayo P, Nakaya H, Pulendran B, Mesirov JP, Haining WN. Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response. Eur J Immunol. 2014;44(1):285–95. doi:10.1002/eji.201343657.
   PubMed Web of Science ®Google Scholar
• Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, Niño D, Arden N, Quarles JM, Couch RB, Belmont JW. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis. 2011;203(7):921–29. doi:10.1093/infdis/jiq156.
   PubMed Web of Science ®Google Scholar
• Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, Varkey J, Veldman T, Kingsmore SF, Huang Y, Lambkin-Williams R, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One. 2013;8(1):e52198. doi:10.1371/journal.pone.0052198.
   PubMed Web of Science ®Google Scholar
• Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70:767–77.
   PubMedGoogle Scholar
• Zhong W, Reed C, Blair PJ, Katz JM, Hancock K. Influenza Serology Working G. Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans. J Infect Dis. 2014;209(7):986–94. doi:10.1093/infdis/jit811.
   PubMed Web of Science ®Google Scholar
• Jegaskanda S, Reading PC, Kent SJ. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine. J Immunol. 2014;193(2):469–75. doi:10.4049/jimmunol.1400432.
   PubMed Web of Science ®Google Scholar
• Gould VMW, Francis JN, Anderson KJ, Georges B, Cope AV, Tregoning JS. Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre. Front Microbiol. 2017;8:900. doi:10.3389/fmicb.2017.00900.
   PubMed Web of Science ®Google Scholar
• Asahi-Ozaki Y, Yoshikawa T, Iwakura Y, Suzuki Y, Tamura S-I, Kurata T, Sata T. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J Med Virol. 2004;74(2):328–35. doi:10.1002/jmv.20173.
   PubMed Web of Science ®Google Scholar
• Treanor J, Wright PF. Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel). 2003;115:97–104.
   PubMedGoogle Scholar
• Forrest BD, Pride MW, Dunning AJ, Capeding MRZ, Chotpitayasunondh T, Tam JS, Rappaport R, Eldridge JH, Gruber WC. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol. 2008;15(7):1042–53. doi:10.1128/CVI.00397-07.
   PubMed Web of Science ®Google Scholar
• Avey S, Mohanty S, Wilson J, Zapata H, Joshi SR, Siconolfi B, Tsang S, Shaw AC, Kleinstein SH. Multiple network-constrained regressions expand insights into influenza vaccination responses. Bioinformatics. 2017;33(14):i208–i216. doi:10.1093/bioinformatics/btx260.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, Frasca D, Gersten M, Mehta AK, Gaujoux R, et al. Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity. 2015;43(6):1186–98. doi:10.1016/j.immuni.2015.11.012.
   PubMed Web of Science ®Google Scholar
• Olafsdottir T, Lindqvist M, Harandi AM. Molecular signatures of vaccine adjuvants. Vaccine. 2015;33(40):5302–07. doi:10.1016/j.vaccine.2015.04.099.
   PubMed Web of Science ®Google Scholar
• Howard LM, Hoek KL, Goll JB, Samir P, Galassie A, Allos TM, Niu X, Gordy LE, Creech CB, Prasad N, et al. Cell-based systems biology analysis of human AS03-adjuvanted H5N1 avian influenza vaccine responses: a phase I randomized controlled trial. PLoS One. 2017;12(1):e0167488. doi:10.1371/journal.pone.0167488.
   PubMed Web of Science ®Google Scholar
• Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines. 2012;11(8):985–94. doi:10.1586/erv.12.61.
   PubMed Web of Science ®Google Scholar
• Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci USA. 2014;111(2):869–74. doi:10.1073/pnas.1321060111.
   PubMed Web of Science ®Google Scholar
• Shen-Orr SS, Furman D. Variability in the immune system: of vaccine responses and immune states. Curr Opin Immunol. 2013;25(4):542–47. doi:10.1016/j.coi.2013.07.009.
   PubMed Web of Science ®Google Scholar